A Change from Subcutaneous to Intravenous Erythropoietin Increases the Cost of Anemia Therapy

Publisher： Karger

E-ISSN： 1660-2110|107|3|c90-c96

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.107, Iss.3, 2007-09, pp. : c90-c96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ERYTHROPOIETIN THERAPY FOR ANEMIA

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 43, Iss. 3, 1995-03 ,pp. : 314-315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Erythropoietin Therapy for Anemia in Two Nonagenarians

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 42, Iss. 1, 1994-01 ,pp. : 114-115

John Wiley & Sons Inc

Access to resources Recommend Favorite

Erythropoietin-Alpha Dosage Requirements in a Provincial Hemodialysis Population: Effect of Switching from Subcutaneous to Intravenous Administration

By  

Nephron Clin Pract, Vol. 102, Iss. 3-4, 2005-11 ,pp. : c88-c92

Karger

Access to resources Recommend Favorite

The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietin

By Devine E. B.   Cross J. T.   Kowdley K. V.   Sullivan S. D.  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1463-1472

Informa Healthcare

Access to resources Recommend Favorite

Erythropoietin Response to Anemia as a Function of Age

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 39, Iss. 1, 1991-01 ,pp. : 30-32

John Wiley & Sons Inc

Access to resources Recommend Favorite